|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,345,812,433 |
|
|
Indirect Value
|
$7,029,594,973 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,375,407,406 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-02-22 |
4 |
B |
$4.75 |
$38,950 |
I/I |
8,200 |
8,117,777 |
1.5 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-03-13 |
4 |
B |
$3.77 |
$31,284 |
I/I |
8,300 |
4,709,015 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-14 |
4 |
B |
$3.15 |
$26,775 |
I/I |
8,500 |
4,436,532 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-13 |
4 |
B |
$0.60 |
$5,400 |
I/I |
9,000 |
8,294,799 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2009-01-23 |
4 |
B |
$3.10 |
$27,879 |
I/I |
9,000 |
5,946,547 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-14 |
4 |
B |
$0.60 |
$5,486 |
I/I |
9,200 |
8,303,999 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-20 |
4 |
B |
$1.26 |
$11,631 |
I/I |
9,200 |
10,786,909 |
1.5 |
- |
|
GYRE |
Gyre Therapeutics |
Direct Beneficial Owner |
|
2009-07-14 |
4 |
B |
$2.99 |
$28,492 |
D/D |
9,516 |
2,700,325 |
2.37 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-02 |
4 |
B |
$0.55 |
$5,356 |
I/I |
9,800 |
8,454,599 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-04 |
4 |
B |
$0.55 |
$5,665 |
I/I |
10,300 |
8,478,299 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-12-30 |
4 |
B |
$2.80 |
$29,680 |
I/I |
10,600 |
5,823,047 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-03 |
4 |
B |
$4.15 |
$46,033 |
I/I |
11,100 |
5,092,500 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-06 |
4 |
B |
$0.59 |
$6,584 |
I/I |
11,200 |
8,019,399 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$0.45 |
$5,400 |
I/I |
12,000 |
8,315,999 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-25 |
4 |
B |
$0.47 |
$5,754 |
I/I |
12,300 |
8,411,399 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-11 |
4 |
B |
$3.07 |
$38,373 |
I/I |
12,500 |
5,507,674 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-03 |
4 |
B |
$0.54 |
$7,216 |
I/I |
13,400 |
8,467,999 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-10 |
4 |
B |
$0.58 |
$8,120 |
I/I |
14,000 |
8,143,099 |
1.5 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-02 |
4 |
S |
$2.83 |
$40,271 |
I/I |
(14,207) |
5,765,693 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-12 |
4 |
B |
$1.35 |
$19,571 |
I/I |
14,511 |
10,267,309 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-12 |
4 |
B |
$5.00 |
$74,000 |
I/I |
14,800 |
4,654,600 |
1.5 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-30 |
4 |
S |
$1.85 |
$28,907 |
D/D |
(15,600) |
5,890,457 |
0 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-16 |
4 |
B |
$3.12 |
$58,919 |
I/I |
18,900 |
4,506,432 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-26 |
4 |
B |
$5.00 |
$103,975 |
I/I |
20,800 |
3,890,100 |
1.5 |
- |
|
GYRE |
Gyre Therapeutics |
Direct Beneficial Owner |
|
2009-07-09 |
4 |
B |
$3.10 |
$66,646 |
D/D |
21,500 |
2,686,609 |
2.45 |
- |
|
195 Records found
|
|
Page 2 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|